4
Changes in Ownership
ATOSSA THERAPEUTICS, INC. Filed Acc 0001193125-26-132644
Chief Financial Officer acquired 63,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Daniel Mark James Chief Financial Officer | 2026-03-26 | Grant or award | +63,000 | 63,000 | D |
Loading xslF345X06/ownership.xml…